Singapore Leads Asia Trials Of Aspirin To Lower Cancer Recurrence
This article was originally published in PharmAsia News
Executive Summary
A Singapore cancer group is leading a large clinical trial in the Southeast Asia region to test the use of aspirin to lower the risk of the recurrence of colorectal cancer following surgery and chemotherapy